The Kimmel Cancer Center at Thomas Jefferson University Named Melanoma Center of Excellence
(PHILADELPHIA) The Kimmel Cancer Center (KCC) at Thomas Jefferson University in Philadelphia has been recognized by The Melanoma Hope Network (MHN) as a Melanoma Center of Excellence (MCE). The KCC is one of the first 10 cancer centers to be designated as an MCE by the network. MHN has designated MCEs across the United States to recognize melanoma treatment centers and doctors, both academic and community-based, that offer exceptional care, knowledge and compassion to patients diagnosed with melanoma, the most dangerous form of skin cancer and also the major cause of death in adult eye tumors.
“The naming of the Kimmel Cancer Center as a Melanoma Center of Excellence reflects the long tradition of translational discovery by Drs. Mastrangelo and Takami Sato,” says KCC director Richard Pestell, M.D., Ph.D., professor and chair of cancer biology at Jefferson Medical College. “Their recent studies have directly impacted the lives of melanoma patients. Those patients who have been successfully treated in Dr. Sato’s clinical trials are a living testimony to the success of his research, and the mission at Jefferson.”
MHN is a non-profit organization established to bring hope, education and direct personal support to patients diagnosed with melanoma. MNH strives to support research, increase patient awareness of clinical trials, and assists primary physicians in finding the appropriate treatments for their patients in their particular stage of melanoma. MHN also acts as a central place for melanoma centers across the country to collaborate, share data and to update and educate their staffs.